JW Asset Management, LLC
Long book
$243.5M
Q1 2026
Positions
19
Top-10 weight
94%
concentration
Last quarter
+49.5%
SPY +14.8%
Turnover
15%
of book per quarter
Strategy in plain words
auto-generated from filingsJW Asset Management, LLC is a concentrated fundamental stock-picker, specialised in healthcare (77% of the long book), running a $243.5M US long book across 19 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: ESTABLISHMENT LABS HOLDINGS, VITA COCO CO INC/THE, CATALYST PHARMACEUTICALS INC, ALPHABET INC-CL C, IREN LTD.
Over the last 9 quarters its long book ran on average 3.3pp per quarter ahead of the S&P 500, beating the index in 3 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-3.2%
Q2 2024
-4.8%
Q3 2024
+3.9%
Q4 2024
-11.5%
Q1 2025
+7.0%
Q2 2025
+2.2%
Q3 2025
+46.3%
Q4 2025
-19.4%
Q1 2026
+49.5%
Sector allocation
Healthcare 77%
Technology 9%
Consumer staples 4%
Consumer discretionary 3%
Other 3%
Financials 2%
Materials 2%
Long book by quarter
What does JW Asset own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| ESTA ESTABLISHMENT LABS HOLDINGS | Healthcare | 3.1M | $173.8M | 71.4% | Held |
| COCO VITA COCO CO INC/THE | Consumer staples | 218.6K | $10.5M | 4.3% | Held |
| CPRX CATALYST PHARMACEUTICALS INC | Healthcare | 388.4K | $9.6M | 3.9% | Held |
| GOOG ALPHABET INC-CL C | Technology | 27.5K | $7.9M | 3.2% | Held |
| IREN IREN LTD | Financials | 164.7K | $5.6M | 2.3% | Held |
| META META PLATFORMS INC-CLASS A | Technology | 8.7K | $5.0M | 2.0% | Held |
| IDR IDAHO STRATEGIC RESOURCES IN | Materials | 143.2K | $4.6M | 1.9% | Held |
| SNDK SANDISK CORP | Technology | 6.5K | $4.1M | 1.7% | New |
| CAVA CAVA GROUP INC | Consumer discretionary | 50.0K | $4.0M | 1.7% | Held |
| RL RALPH LAUREN CORP | Other | 10.0K | $3.4M | 1.4% | Held |
| HRTX HERON THERAPEUTICS INC | Healthcare | 3.8M | $3.0M | 1.2% | +2.2% |
| ONON ON HOLDING AG-CLASS A | Other | 83.0K | $2.8M | 1.2% | -39.0% |
| NVDA NVIDIA CORP | Technology | 15.3K | $2.7M | 1.1% | Held |
| MU MICRON TECHNOLOGY INC | Technology | 7.0K | $2.4M | 1.0% | New |
| FIVE FIVE BELOW | Consumer discretionary | 10.0K | $2.3M | 0.9% | +42.9% |
| LQDA LIQUIDIA CORP | Healthcare | 16.2K | $610K | 0.3% | -83.8% |
| HITI HIGH TIDE INC | Consumer discretionary | 102.1K | $234K | 0.1% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 8, 2026 | 19 | $243.5M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 6, 2026 | 18 | $307.2M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 7, 2025 | 17 | $208.4M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 11, 2025 | 19 | $202.9M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 9, 2025 | 18 | $176.6M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 7, 2025 | 17 | $210.4M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 8, 2024 | 13 | $221.5M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 8, 2024 | 13 | $242.7M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 7, 2024 | 14 | $273.7M | canonical | SEC ↗ |